Functional and molecular characterization of Aspergillus fumigatus phosphoglucomutase (Pgm): a potential target for
Conrad C Achilonu1, Theodore J Kottom1, Andrew H Limper1
1Thoracic Diseases Research Unit, Departments of Medicine and Biochemistry, Mayo Clinic, Rochester, MN, USA.
Abstract:
Introduction. Aspergillus fumigatus phosphoglucomutase (AfPGM) is a central enzyme in fungal carbohydrate metabolism that catalyses the interconversion of glucose-1-phosphate and glucose-6-phosphate, generating precursors such as uridine diphosphate glucose required for the synthesis of key cell wall polysaccharides.Hypothesis/Gap Statement. Although AfPGM has been implicated in fungal viability and cell wall integrity, further functional and molecular characterization is required to better define its role in cell wall-associated processes and to evaluate its potential as a selective antifungal target.Aim. This study aimed to further characterize the functional contribution of AfPGM to fungal growth, cell wall-related phenotypes, biofilm formation and enzymatic activity.Methodology. A conditional A. fumigatus PalcA::pgm mutant was used to assess growth, soluble β-glucan levels and biofilm formation. Functional complementation was evaluated by heterologous expression of Afpgm in a Saccharomyces cerevisiae pgm2Δ strain. Enzymatic inhibition was examined using the isothiazolone compound ISFP10.Results. Reduced AfPGM activity was associated with impaired growth, altered cell wall-related phenotypes, decreased soluble β-glucan levels and diminished biofilm biomass. Expression of Afpgm restored growth and sedimentation defects in the yeast pgm2Δ mutant to WT levels, confirming functional conservation. ISFP10 inhibited AfPGM activity and disrupted associated fungal phenotypes.Conclusion. These findings further define the functional role of AfPGM in fungal carbohydrate metabolism and cell wall-associated biology. The selective inhibition of AfPGM relative to human phosphoglucomutase supports its potential as a promising target for the development of novel antifungal therapies.
Insights
Aspergillus fumigatus phosphoglucomutase (AfPGM) is crucial for fungal growth and cell wall integrity. Inhibiting AfPGM selectively offers a promising strategy for developing new antifungal therapies.
Area of Science:
- Biochemistry
- Mycology
- Molecular Biology
Background:
- Aspergillus fumigatus phosphoglucomutase (AfPGM) is a key enzyme in fungal carbohydrate metabolism.
- AfPGM generates essential precursors for cell wall polysaccharide synthesis.
- Its precise role in fungal viability and cell wall integrity requires further elucidation.
Purpose of the Study:
- To characterize the functional role of AfPGM in fungal growth.
- To investigate AfPGM's contribution to cell wall phenotypes and biofilm formation.
- To evaluate AfPGM as a potential antifungal target.
Main Methods:
- Utilized a conditional A. fumigatus PalcA::pgm mutant to assess growth and biofilm formation.
- Performed functional complementation by expressing Afpgm in a Saccharomyces cerevisiae pgm2Δ strain.
- Examined enzymatic inhibition using the isothiazolone compound ISFP10.
Main Results:
- Reduced AfPGM activity led to impaired growth, altered cell wall phenotypes, and decreased biofilm biomass.
- Heterologous expression of Afpgm restored wild-type phenotypes in yeast, confirming functional conservation.
- ISFP10 effectively inhibited AfPGM activity and disrupted fungal phenotypes.
Conclusions:
- AfPGM plays a significant role in fungal carbohydrate metabolism and cell wall biology.
- Selective inhibition of AfPGM by ISFP10 highlights its potential as an antifungal target.
- AfPGM represents a promising avenue for novel antifungal drug development.
Related Concept Videos
Antifungal Agents
Pharmacogenomics: Identification of New Drug Targets


